| Announce Date | 11/05/2025 |
| EPS Normalized Actual | $12.24 (Beat by $11.63) |
| EPS GAAP Actual | $12.24 (Beat by $11.63) |
| Revenue Actual | $0.9948B |
| Revenue Surprise | Beat by $994.8M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Oct 2028 | 6.59 | 11.38 | 6.29762 | 6.88851 | 1 |
| Sep 2028 | 6.59 | 11.38 | 6.43017 | 6.75959 | 2 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 3.03 | 3.03 | 0.9948B | -42.45% | 994.8M |
| FQ3 2025 (Jul 2025) | 1.1 | 1.1 | 1.1347B | -28.16% | 1134.7M |
| FQ2 2025 (Apr 2025) | 0.82 | 0.82 | 1.3857B | 1.06% | 1385.7M |
| FQ1 2025 (Jan 2025) | 0.33 | 0.33 | 1.2658B | 4.74% | 1265.8M |
| FQ4 2024 (Oct 2024) | 0 | 0 | 1.4171B | 7.67% | 1417.1M |
| FQ3 2024 (Jul 2024) | 1.51 | 1.51 | 1.4542B | 8.52% | 1454.2M |
| FQ2 2024 (Apr 2024) | 0.77 | 0.77 | 1.371B | 4.53% | 1371M |
| FQ1 2024 (Jan 2024) | 2.63 | 2.63 | 1.2058B | 100% | 1205.8M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2028 (Oct 2028) | 1.92 | -- | 1.92 | 1.92 | 1 |
| FQ3 2028 (Jul 2028) | 1.86 | -- | 1.86 | 1.86 | 1 |
| FQ2 2028 (Apr 2028) | 1.77 | -- | 1.77 | 1.77 | 1 |
| FQ1 2028 (Jan 2028) | 1.04 | -- | 1.04 | 1.04 | 1 |
| FQ4 2027 (Oct 2027) | 1.92 | -- | 1.91155 | 1.92845 | 1 |
| FQ3 2027 (Jul 2027) | 1.86 | -- | 1.85181 | 1.86819 | 1 |
| FQ2 2027 (Apr 2027) | 1.77 | -- | 1.76221 | 1.77779 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2028 (Oct 2028) | 1.62B | -- | 1.62B | 1.62B | 1 |
| FQ3 2028 (Jul 2028) | 1.66B | -- | 1.66B | 1.66B | 1 |
| FQ2 2028 (Apr 2028) | 1.61B | -- | 1.61B | 1.61B | 1 |
| FQ1 2028 (Jan 2028) | 1.43B | -- | 1.43B | 1.43B | 1 |
| FQ4 2027 (Oct 2027) | 1.62B | -- | 1.61B | 1.62B | 1 |
| FQ3 2027 (Jul 2027) | 1.66B | -- | 1.65B | 1.66B | 1 |
| FQ2 2027 (Apr 2027) | 1.61B | -- | 1.6B | 1.61B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
0
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 3.03 | 3.03 | 100% | |
| FQ3 2025 (Jul 2025) | 1.1 | 1.1 | 100% | |
| FQ2 2025 (Apr 2025) | 0.82 | 0.82 | 100% | |
| FQ1 2025 (Jan 2025) | 0.33 | 0.33 | 100% | |
| FQ4 2024 (Oct 2024) | 0 | 0 | NAN% | |
| FQ3 2024 (Jul 2024) | 1.51 | 1.51 | 100% | |
| FQ2 2024 (Apr 2024) | 0.77 | 0.77 | 100% | |
| FQ1 2024 (Jan 2024) | 2.63 | 2.63 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | $0B | $0.99B | $994.8M | 100% |
| FQ3 2025 (Jul 2025) | $0B | $1.13B | $1134.7M | 100% |
| FQ2 2025 (Apr 2025) | $0B | $1.39B | $1385.7M | 100% |
| FQ1 2025 (Jan 2025) | $0B | $1.27B | $1265.8M | 100% |
| FQ4 2024 (Oct 2024) | $0B | $1.42B | $1417.1M | 100% |
| FQ3 2024 (Jul 2024) | $0B | $1.45B | $1454.2M | 100% |
| FQ2 2024 (Apr 2024) | $0B | $1.37B | $1371M | 100% |
| FQ1 2024 (Jan 2024) | $0B | $1.21B | $1205.8M | 100% |